Blog Post
Electroacupuncture and Breast Cancer Survivors: What a New Study Means for Our Patients
Breast cancer survival rates have never been higher, but for the more than four million survivors in North America, surviving treatment is often just the beginning. Brain fog, fatigue, insomnia, and anxiety can linger for months or years after treatment ends, and conventional oncology doesn’t have strong tools to address them.
A study published this April in the Journal of the National Cancer Institute suggests electroacupuncture may be one of those tools.
What the Study Found
The UC Irvine-led randomized, double-blind pilot trial enrolled 35 breast cancer survivors reporting cognitive impairment, fatigue, insomnia, and psychological distress. Participants received ten weekly sessions of electroacupuncture targeting either neuropsychiatric-specific acupoints or nonspecific control acupoints.
Nearly 43 percent of the targeted group showed measurable cognitive improvement, specifically in attention, compared to 12.5 percent in the control group. Brain imaging showed increased gray matter volume, neuroinflammation biomarkers improved, and the treatment was well tolerated. The lead researcher noted that patients often feel unprepared for the cognitive and emotional challenges that persist after cancer treatment, and that robust evidence is needed to show how integrative interventions can be incorporated into survivorship care.
Why Point Selection Matters
Both groups received electroacupuncture, but only the group treated at acupoints specifically linked to neurological and psychological function showed significant results. The researchers concluded that where acupuncture is applied matters. That finding speaks directly to the diagnostic sophistication that registered TCM practitioners bring to their work.
What This Means in Practice
Breast cancer is the most commonly diagnosed cancer among women in Canada. Many of our patients are survivors navigating fatigue and cognitive symptoms that their oncology teams aren’t equipped to address. This study gives us more to stand on in those conversations, and in conversations with the oncologists and other providers who may be part of their care. Electroacupuncture for neuropsychiatric symptom clusters now has a randomized controlled trial behind it, published in a journal oncologists read.
The research is catching up to what many of us have seen in practice. The question is whether Ontario’s healthcare system is ready to catch up too.
Source: Chan et al., Journal of the National Cancer Institute, April 2026.